Proven Checks Buyers Miss In A Batch Manufacturing Record
The first commercial batch from a new intermediate supplier is not a formality. Here is the checklist, the five approval outcomes, and how to log the call.
5-Bromo-4-fluoro-1-methylindazole; 1H-Indazole, 5-bromo-4-fluoro-1-methyl-; 5-Bromo-4-fluoro-1-m; Orforglipron Intermediates
CAS: 1784678-61-0
Chemical Formula: C₈H₆BrFN₂
Molecular Weight: 229.05
Availability: R&D; Commercialization
⬤ CAS No.1784678-61-0
⬤ Our Packaging type:
20kg barrel;5kg barrel;1kg bag;500g bag ; Customized Packaging
| Product Name | 5-bromo-4-fluoro-1-methyl-1H-indazole |
| CAS.No | 1784678-61-0 |
| Molecular Formula | C₈H₆BrFN₂ |
| Molecular Weight | 229.05 |
| Related Categories | Orforglipron Intermediates |
| Appearance | solid |
| Boiling Point | 293.4±20.0 °C(Predicted) |
| Density | 1.70±0.1 g/cm³ (Predicted) |
| Acidity coefficient(pKa) | -0.38±0.30 (Predicted) |
| Flash Point | 131.3±21.8 °C (Predicted) |
| Chemical Structure | The compound is a halogenated indazole derivative, and its structural characteristics are that the benzene ring is fused with the pyrazole ring, the bromine and fluorine atoms are connected at the 5-position and 4-position respectively, and the methyl group is connected at the 1-position. |
| Dangerous goods signs | GHS07 Warning |
| Hazard Labeling | H302 (Note: Harmful if swallowed) |
| Application | 5-Bromo-4-fluoro-1-methyl-1H-indazole is an important intermediate in the synthesis of potential drug candidates in various therapeutic areas, including cancer, neurodegenerative diseases, and infectious diseases. |
Reliable Global Partner
“Tianming Pharmaceutical has redefined reliability for us. Their ability to deliver high-potency APIs and intermediates under tight deadlines—is unmatched. The team’s transparency in documentation and proactive updates make them a stress-free partner. A true backbone for our operations!”
March 18, 2024
Outstanding Technical Guidance
“Few suppliers align so perfectly with EU GMP requirements. Tianming’s commitment to audit-ready quality systems, batch traceability, and purity consistency has streamlined our production processes. Their diligence eliminates regulatory risks—a rare advantage in today’s market.”
February 15, 2024
Beyond Supplier, A Solutions Partner
“Tianming’s technical team doesn’t just deliver materials—they solve problems. When we faced stability challenges with a niche compound, their scientists proposed a tailored purity adjustment that saved our project timeline. Their agility transforms obstacles into opportunities.”
June 15, 2024
Strategic Growth Ally
“Over 5+ years, Tianming has consistently adapted to our evolving needs—whether scaling volumes or supporting custom synthesis projects. Their ethical pricing models and long-term vision make them more than a vendor; they’re integral to our competitive edge.”
April 27, 2024
The first commercial batch from a new intermediate supplier is not a formality. Here is the checklist, the five approval outcomes, and how to log the call.
The first commercial batch from a new intermediate supplier is not a formality. Here is the checklist, the five approval outcomes, and how to log the call.
A buyer-side decision tree for handling an intermediate supplier change notice — what to accept, contest, or reject, and how to log the call.
Manufacturer and supplier of pharmaceutical APIs and intermediates. Contact us for technical support and sourcing solutions.